SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending with significant buzz, driven by renewed analyst optimism and intense speculation around a potential short squeeze due to its high short interest. The community is keenly awaiting announcements from the ongoing J.P. Morgan Healthcare Conference, hoping for pivotal news on partnerships or strategic updates for its Matrix-M platform. This comes amidst strong calls for tangible execution from management as investor scrutiny intensifies.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is a top trending stock after reporting impressive preliminary revenue growth, positioning it as a rapidly expanding player in the defense drone industry. The community is actively anticipating updates from the CEO's upcoming conference appearance and the highly-watched Drone Dominance Gauntlet, as investors seek clarity on future contracts and production capabilities for U.S.-made unmanned systems amidst heightened global defense needs.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is captivating market attention amid escalating geopolitical tensions and recent CME margin adjustments, sparking intense debate on its future trajectory. Bulls confidently point to silver's strategic industrial demand and its role as a hedge against currency debasement, while a vocal bear contingent anticipates a significant pullback from its parabolic ascent. This strong conviction on both sides continues to drive extreme volatility and a notable short squeeze within the commodity.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing notable volatility and a price dip, igniting strong community debate around its immediate future. Many investors are seizing the "buy the dip" opportunity, emphasizing the company's robust fundamentals, zero debt, and strategic positioning in agentic AI, despite others citing recent CEO share sales and broader software sector weakness as driving factors. This sharp divergence in sentiment underscores high expectations for either a continued pullback or a significant upward reversal.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as a major point of contention, with recent analyst downgrades intensifying concerns about its market position against a backdrop of increasing AI-powered competition. The community is sharply divided, debating whether the creative software giant is a deeply undervalued opportunity or facing significant headwinds from rivals like Apple and evolving AI solutions.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is generating significant buzz, with many in the community celebrating its impressive breakout to new all-time highs as money rotates into small-cap stocks. This strong upward momentum is fueling discussions about whether small caps will continue to lead, particularly with upcoming economic data and the anticipated Supreme Court ruling on tariffs potentially influencing market sentiment.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is experiencing extreme volatility following the FDA's request for additional data to characterize FILSPARI's clinical benefit for Focal Segmental Glomerulosclerosis (FSGS). The community is sharply divided, with many fearing a Complete Response Letter and significant further downside, while others view the substantial dip as an attractive buying opportunity, emphasizing the drug's strong efficacy and the critical unmet need for a first-in-class FSGS treatment.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan is trending following its latest earnings report, which despite beating expectations, saw the stock dip due to investor focus on rising credit loss provisions and a proposed credit card interest rate cap. While this regulatory concern is a key talking point impacting the financial sector, the community is also actively discussing JPMorgan's evolving, more bullish stance on Bitcoin and its deepening involvement in blockchain technology.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending due to recent positive developments in its vaccine pipeline, including global regulatory submissions for its flu vaccine and a next-generation COVID-19 shot, alongside significant funding for a pandemic influenza candidate. This news is fueling intense debate among investors, with many anticipating a short squeeze and emphasizing the long-term potential of its oncology partnership with Merck, despite persistent skepticism from others. The stock's performance notably outpaces the broader healthcare sector, signaling a potential shift in focus beyond its initial pandemic-era narrative.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

Ambitions Enterprise Management Co. L.L.C. (AHMA) is actively trending with a significant surge in trading volume and rapid price movement. The community attributes this to its low float and potential for a short squeeze, frequently comparing its trajectory to past explosive runners like SMX. Traders are intently watching key resistance levels, with many speculating on further upside despite a lack of specific recent news driving the momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$C Option 1: The High-Probability Bull Call Spread (Recommended) 
BUY: 1x Jan 16 $117.00 Call 
 
SELL: 1x Jan 16 $122.00 Call 
 
Estimated Net Debit: $2.15 – $2.30 ($215–$230 per spread). 
 
Why: If Citi beats and rallies just 3% to $120, this spread will increase in value by ~40%. By selling the $122 Call, you protect yourself against the &quot;IV Crush&quot; that killed your GBX and SIFY plays. 
 
Option 2: The &quot;Lotto&quot; Ticket (Aggressive) 
BUY: Citigroup Jan 16 $120.00 Call 
 
Estimated Cost: $1.45 ($145 per contract). 
 
Risk: High. If Citi is flat tomorrow, this contract will lose 50% of its value by 10:00 AM.

StockTwits Web

Citigroup Inc

 Option 1: The High-Probability Bull Call Spread (Recommended) 
BUY: 1x Jan 16 $117.00 Call 
 
SELL: 1x Jan 16 $122.00 Call 
 
Estimated Net Debit: $2.15 – $2.30 ($215–$230 per spread). 
 
Why: If Citi beats and rallies just 3% to $120, this spread will increase in value by ~40%. By selling the $122 Call, you protect yourself against the "IV Crush" that killed your GBX and SIFY plays. 
 
Option 2: The "Lotto" Ticket (Aggressive) 
BUY: Citigroup Jan 16 $120.00 Call 
 
Estimated Cost: $1.45 ($145 per contract). 
 
Risk: High. If Citi is flat tomorrow, this contract will lose 50% of its value by 10:00 AM.